欧美午夜精品久久久久免费视-亚洲国产精品无码久久久-鲁鲁狠狠狠7777一区二区-特黄aaaaaaa片免费视频

Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2,3,4,6-TETRA-O-BENZYL-D-GLUCOPYRANOSE is a significant D-glucopyranose derivative that plays a crucial role in various chemical and pharmaceutical processes. It is characterized by the presence of four benzyl groups attached to the hydroxyl groups at the 2, 3, 4, and 6 positions, which provide steric hindrance and protect the molecule during reactions. This unique structure makes it a valuable intermediate in the synthesis of complex carbohydrates and related compounds.

6564-72-3

Post Buying Request

6564-72-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6564-72-3 Usage

Uses

Used in Pharmaceutical Industry:
2,3,4,6-TETRA-O-BENZYL-D-GLUCOPYRANOSE is used as an intermediate in the synthesis of Voglibose and Dapagliflozin, which are important drugs for the treatment of type 2 diabetes. Its role in the synthesis process is crucial for the development of these therapeutic agents.
Used in Organic Chemistry:
2,3,4,6-TETRA-O-BENZYL-D-GLUCOPYRANOSE is used as a key building block in the preparation of α-glucopyranosyl chloride, a versatile reagent for the synthesis of various 1-C-α-D-glucopyranose derivatives. This allows for the creation of a wide range of complex carbohydrate structures with potential applications in various fields.
Used in Carbohydrate Chemistry:
2,3,4,6-TETRA-O-BENZYL-D-GLUCOPYRANOSE is used as a protecting group in glucosylations and other carbohydrate-related reactions. The benzyl groups provide steric protection, enabling selective reactions to occur at specific sites on the molecule. This selective reactivity is essential for the synthesis of complex carbohydrate structures with precise control over the product's structure.

Check Digit Verification of cas no

The CAS Registry Mumber 6564-72-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,5,6 and 4 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 6564-72:
(6*6)+(5*5)+(4*6)+(3*4)+(2*7)+(1*2)=113
113 % 10 = 3
So 6564-72-3 is a valid CAS Registry Number.
InChI:InChI=1/C34H36O6/c35-34-33(39-24-29-19-11-4-12-20-29)32(38-23-28-17-9-3-10-18-28)31(37-22-27-15-7-2-8-16-27)30(40-34)25-36-21-26-13-5-1-6-14-26/h1-20,30-35H,21-25H2/t30-,31-,32+,33-,34?/m1/s1

6564-72-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H31595)  2,3,4,6-Tetra-O-benzyl-alpha-D-glucopyranose, 98%   

  • 6564-72-3

  • 1g

  • 290.0CNY

  • Detail
  • Alfa Aesar

  • (H31595)  2,3,4,6-Tetra-O-benzyl-alpha-D-glucopyranose, 98%   

  • 6564-72-3

  • 5g

  • 972.0CNY

  • Detail

6564-72-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,3,4,6-Tetra-O-benzyl-D-glucopyranose

1.2 Other means of identification

Product number -
Other names 2,3,4,6-TETRA-O-BENZYL-D-GLUCOPYRANOSE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6564-72-3 SDS

6564-72-3Synthetic route

methyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside

methyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

Conditions
ConditionsYield
With sulfuric acid; acetic acid In water for 2h; Reflux;97%
With hydrogenchloride In water; acetic acid at 85℃; for 7h; Reflux;63%
With sulfuric acid In methanol; water; acetic acid41%
(Z)-prop-1'-enyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside
139684-64-3

(Z)-prop-1'-enyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

Conditions
ConditionsYield
With hydrogenchloride In methanol; acetone for 0.5h;94%
methyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside
104992-64-5

methyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

Conditions
ConditionsYield
With calcium carbonate; mercury dichloride In water; acetonitrile for 5h; Heating;77%
2-benzothiazolyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside
70893-32-2

2-benzothiazolyl 2,3,4,6-tetra-O-benzyl-1-thio-β-D-glucopyranoside

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

Conditions
ConditionsYield
With N-Bromosuccinimide; water In acetone at 20℃; for 0.5h; Concentration;73.3%
(2R,3R,4S,5R,6R)-3,4,5-Tris-benzyloxy-2-benzyloxymethyl-6-(2,2-dichloro-1-methyl-vinyloxy)-tetrahydro-pyran
660851-96-7

(2R,3R,4S,5R,6R)-3,4,5-Tris-benzyloxy-2-benzyloxymethyl-6-(2,2-dichloro-1-methyl-vinyloxy)-tetrahydro-pyran

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

Conditions
ConditionsYield
With trifluoroacetic acid at 65℃; for 3h;65%
p-methylphenyl 2,3,4,6-tetra-O-benzyl-thio-β-D-glucopyranoside
131531-76-5

p-methylphenyl 2,3,4,6-tetra-O-benzyl-thio-β-D-glucopyranoside

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

Conditions
ConditionsYield
With N-Bromosuccinimide; water In water; acetone at 20℃; for 0.5h; Concentration;62%
methyl 3β-amino-12α-O-(α-D-glucopyranosyl-1')-deoxycholate

methyl 3β-amino-12α-O-(α-D-glucopyranosyl-1')-deoxycholate

methyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside
84799-77-9

methyl 2,3,4,6-tetra-O-benzyl-D-glucopyranoside

A

3β-amino-24-hydroxy-7α,12α-di(1'α-glucosyl)-5β-cholane

3β-amino-24-hydroxy-7α,12α-di(1'α-glucosyl)-5β-cholane

B

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

Conditions
ConditionsYield
With sulfuric acid In acetic acidA n/a
B 53%
Conditions
ConditionsYield
(i) HCl, AllOH, (ii) (benzylation), (iii) aq. HCl, acetone; Multistep reaction;
methyl 2,3,4,6-tetra-O-benzyl α-D-glucopyranoside
19488-61-0

methyl 2,3,4,6-tetra-O-benzyl α-D-glucopyranoside

A

1-O-acetyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose
80300-30-7

1-O-acetyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose

B

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

C

2,3,4,6-tetra-O-benzyl-D-glucopyranoside
59531-24-7

2,3,4,6-tetra-O-benzyl-D-glucopyranoside

Conditions
ConditionsYield
With trifluorormethanesulfonic acid; acetic acid for 4h; Yield given. Yields of byproduct given;
With trifluorormethanesulfonic acid; acetic acid for 240h; Yield given. Yields of byproduct given;
2,3,4,6-tetra-O-benzyl-D-glucopyranoside
59531-24-7

2,3,4,6-tetra-O-benzyl-D-glucopyranoside

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

Conditions
ConditionsYield
With pyridine; dmap In dichloromethane at 22℃; Equilibrium constant;
isopropyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside
114967-51-0

isopropyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside

A

1-O-acetyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose
80300-30-7

1-O-acetyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose

B

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

C

2,3,4,6-tetra-O-benzyl-D-glucopyranoside
59531-24-7

2,3,4,6-tetra-O-benzyl-D-glucopyranoside

Conditions
ConditionsYield
With trifluorormethanesulfonic acid; acetic acid for 3h; Yield given. Yields of byproduct given;
2-(trimethylsilyl)ethyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside
115969-49-8

2-(trimethylsilyl)ethyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside

A

1-O-acetyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose
80300-30-7

1-O-acetyl-2,3,4,6-tetra-O-benzyl-D-glucopyranose

B

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

C

2,3,4,6-tetra-O-benzyl-D-glucopyranoside
59531-24-7

2,3,4,6-tetra-O-benzyl-D-glucopyranoside

Conditions
ConditionsYield
With trifluorormethanesulfonic acid; acetic acid for 0.5h;
2-benzyloxyethyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside
82231-40-1

2-benzyloxyethyl 2,3,4,6-tetra-O-benzyl-β-D-glucopyranoside

A

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

B

2-benzyloxyethyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside

2-benzyloxyethyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside

Conditions
ConditionsYield
With titanium tetrachloride In dichloromethane for 0.00111111h; Ambient temperature; Yield given. Yields of byproduct given;
1,3,4,6-tetra-O-benzyl-β-D-fructofuranosyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside
18685-22-8

1,3,4,6-tetra-O-benzyl-β-D-fructofuranosyl 2,3,4,6-tetra-O-benzyl-α-D-glucopyranoside

2,3,4,6-tetra-O-benzyl-D-glucopyranose
6564-72-3

2,3,4,6-tetra-O-benzyl-D-glucopyranose

Conditions
ConditionsYield
With acetic acid

6564-72-3Relevant articles and documents

Discovery of Salidroside-Derivated Glycoside Analogues as Novel Angiogenesis Agents to Treat Diabetic Hind Limb Ischemia

Liu, Caiping,Han, Jingxuan,Marcelina, Olivia,Nugrahaningrum, Dyah Ari,Huang, Song,Zou, Meijuan,Wang, Guixue,Miyagishi, Makoto,He, Yun,Wu, Shourong,Kasim, Vivi

, p. 135 - 162 (2022/01/14)

Therapeutic angiogenesis is a potential therapeutic strategy for hind limb ischemia (HLI); however, currently, there are no small-molecule drugs capable of inducing it at the clinical level. Activating the hypoxia-inducible factor-1 (HIF-1) pathway in skeletal muscle induces the secretion of angiogenic factors and thus is an attractive therapeutic angiogenesis strategy. Using salidroside, a natural glycosidic compound as a lead, we performed a structure-activity relationship (SAR) study for developing a more effective and druggable angiogenesis agent. We found a novel glycoside scaffold compound (C-30) with better efficacy than salidroside in enhancing the accumulation of the HIF-1α protein and stimulating the paracrine functions of skeletal muscle cells. This in turn significantly increased the angiogenic potential of vascular endothelial and smooth muscle cells and, subsequently, induced the formation of mature, functional blood vessels in diabetic and nondiabetic HLI mice. Together, this study offers a novel, promising small-molecule-based therapeutic strategy for treating HLI.

Electrochemical Synthesis of Glycosyl Fluorides Using Sulfur(VI) Hexafluoride as the Fluorinating Agent

Kim, Sungjin,Nagorny, Pavel

, p. 2294 - 2298 (2022/04/07)

This manuscript describes the electrochemical synthesis of 17 different glycosyl fluorides in 73-98% yields on up to a 5 g scale that relies on the use of SF6 as an inexpensive and safe fluorinating agent. Cyclic voltammetry and related mechanistic studies carried out subsequently suggest that the active fluorinating species generated through the cathodic reduction of SF6 are transient under these reductive conditions and that the sulfur and fluoride byproducts are effectively scavenged by Zn(II) to generate benign salts.

Regioselective Anomeric O-Benzyl Deprotection in Carbohydrates

Anjaneyulu, Bandi,Rao, Boddu Umamaheswara,Sridhar, Perali Ramu

supporting information, p. 5665 - 5668 (2021/11/11)

A highly regioselective hydrogenolysis of the anomeric benzyl group is reported. The reaction involves selective acetolysis of benzyl acetals of various mono- and di-saccharides using 10 % Pd/C under hydrogen atmosphere in the presence of Na2CO

Design, synthesis, and biological evaluation of desmuramyl dipeptides modified by adamantyl-1,2,3-triazole

?kalamera, Dani,Antica, Mariastefania,Car, ?eljka,Dra?enovi?, Josip,Milkovi?, Lidija,Perokovi?, Vesna Petrovi?,Ribi?, Rosana,Stojkovi?, Ranko,Tomi?, Sr?anka

, (2021/11/01)

Muramyl dipeptide (MDP) is the smallest peptidoglycan fragment able to trigger the immune response. Structural modification of MDP can lead to the preparation of analogs with improved immunostimulant properties, including desmuramyl peptides (DMPs). The aim of this work was to prepare the desmuramyl peptide (L-Ala-D-Glu)-containing adamantyl-triazole moiety and its mannosylated derivative in order to study their immunomodulatory activities in vivo. The adjuvant activity of the prepared compounds was evaluated in a murine model using ovalbumin as an antigen, and compared to the reference adjuvant ManAdDMP. The results showed that the introduction of the lipophilic adamantyl-triazole moiety at the C-terminus of L-Ala-D-Glu contributes to the immunostimulant activity of DMP, and that mannosylation of DMP modified with adamantyl-triazole causes the amplification of its immunostimulant activity.

Synthesis and conformational analysis of vicinally branched trisaccharide β-d-Galf-(1 → 2)-[β-d-Galf-(1 → 3)-]-α-GalpfromCryptococcus neoformansgalactoxylomannan

Dorokhova, Vera S.,Gerbst, Alexey G.,Komarova, Bozhena S.,Previato, José O.,Previato, Lúcia Mendon?a,Dmitrenok, Andrey S.,Shashkov, Alexander S.,Krylov, Vadim B.,Nifantiev, Nikolay E.

supporting information, p. 2923 - 2931 (2021/04/14)

The synthesis of a vicinally branched trisaccharide composed of twod-galactofuranoside residues attachedviaβ-(1 → 2)- and β-(1 → 3)-linkages to the α-d-galactopyranoside unit has been performed for the first time. The reported trisaccharide represents the galactoxylomannan moiety first described in 2017, which is the capsular polysaccharide of the opportunistic fungal pathogenCryptococcus neoformansresponsible for life-threatening infections in immunocompromised patients. The NMR-data reported here for the synthetic model trisaccharide are in good agreement with the previously assessed structure of galactoxylomannan and are useful for structural analysis of related polysaccharides. The target trisaccharide as well as the constituent disaccharides were analyzed by a combination of computational and NMR methods to demonstrate good convergence of the theoretical and experimental results. The results suggest that the furanoside ring conformation may strongly depend on the aglycon structure. The reported conformational tendencies are important for further analysis of carbohydrate-protein interaction, which is critical for the host response towardC. neoformansinfection.

Synthesis of nature product kinsenoside analogues with anti-inflammatory activity

Song, Wei,Sun, Yong,Xu, Lintao,Sun, Yajing,Li, Tianlu,Peng, Peng,Lou, Hongxiang

supporting information, (2020/12/02)

Kinsenoside is the major bioactive component from herbal medicine with a broad range of pharmacological functions. Goodyeroside A, an epimer of kinsenoside, remains less explored. In this report we chemically synthesized kinsenoside, goodyeroside A and their analogues with glycan variation, chirality inversion at chiral center(s), and bioisosteric replacement of lactone with lactam. Among these compounds, goodyeroside A and its mannosyl counterpart demonstrated superior anti-inflammatory efficacy. Furthermore, goodyeroside A was found to suppresses inflammatory through inhibiting NF-κB signal pathway, effectively. Structure-activity relationship is also explored for further development of more promising kinsenoside analogues as drug candidates.

Beta-D-glucose short-chain fatty acid ester compound as well as preparation method and application thereof

-

, (2021/04/03)

The invention discloses a beta-D-glucose short-chain fatty acid ester compound as well as a preparation method and application thereof, and belongs to the technical field of organic synthesis. The compound is a compound shown as a formula I, or a stereoisomer, a pharmaceutically acceptable salt, a solvate or a prodrug of the compound shown as the formula I. The formula is as shown in the description, wherein R is a methyl group, an ethyl group, a propyl group, a propylene group, an isopropylidene group, a butyl group, a butylidene group, an isobutylidene group, an amyl group, a pentylidene group or an isoamylidene group. The compound has potential prevention and treatment effects on diabetes, hyperlipidemia, atherosclerosis, Alzheimer's disease, cardiovascular and cerebrovascular diseases,inflammation, tumors and depression.

Self-Promoted Glycosylation for the Synthesis of β-N-Glycosyl Sulfonyl Amides

Ma?a, Patrycja,Pedersen, Christian Marcus

, p. 5685 - 5689 (2021/08/30)

N-Glycosyl N-sulfonyl amides have been synthesized by a self-promoted glycosylation, i. e. without any catalysts, promotors or additives. When the reactions were carried out at lower temperatures a mixture of N- and O-glycosides were observed, where the latter rearranged to give the β-N-glycosides at elevated temperatures. By this method sulfonylated asparagine derivatives can be selectively β-glycosylated in high yields by trichloroacetimidate glycosyl donors of different reactivity including protected glucosamine derivatives. The chemoselectivity in the glycosylations as well as the rearrangements from O-glycosides to β-N-glycosides gives information of the glycosylation mechanism. This method gives access to glycosyl sulfonyl amides under mild conditions.

Tuning the activity of iminosugars: novel N-alkylated deoxynojirimycin derivatives as strong BuChE inhibitors

Ahuja-Casarín, Ana I.,Merino-Montiel, Penélope,Vega-Baez, José Luis,Montiel-Smith, Sara,Fernandes, Miguel X.,Lagunes, Irene,Maya, Inés,Padrón, José M.,López, óscar,Fernández-Bola?os, José G.

, p. 138 - 146 (2020/11/27)

We have designed unprecedented cholinesterase inhibitors based on 1-deoxynojirimycin as potential anti-Alzheimer’s agents. Compounds are comprised of three key structural motifs: the iminosugar, for interaction with cholinesterase catalytic anionic site (

Method for continuously synthesizing benzyl-substituted glucolactone by adopting microchannel reaction device

-

Paragraph 0012; 0043; 0045; 0047; 0050; 0052-0053; 0055, (2021/06/21)

The invention discloses a method for continuously synthesizing benzyl-substituted glucolactone by adopting a microchannel reaction device. The method comprises the following steps: taking methyl-alpha-D-mannopyranoside as an initial raw material, preparing the methyl-alpha-D-mannopyranoside into an old organic solvent solution, and reacting the old organic solvent solution with an organic solvent solution of benzyl chloride in a first microreactor to generate methyl glucose with hydroxyl protected by benzyl; reacting a homogeneous solution formed by mixing a reaction solution of benzyl-substituted gluconic acid and a small amount of hydrochloric acid solution in a second microreactor for demethylation to generate hydroxyl benzyl-substituted glucose; and finally, reacting the reaction solution with an aqueous solution of hydrogen peroxide and sodium hydroxide and an organic solvent solution of tetramethylpiperidine nitrogen oxide in a third microreactor to generate the high-purity hypoglycemic drug Dapagliflozin intermediate benzyl substituted glucolactone. The method disclosed by the invention is higher in heat and mass transfer efficiency and easier to industrially amplify, the initial materials are simple, cheap and easily available, the process is simple, the obtained intermediate is high in purity and high in yield, the production cost can be effectively reduced, and the method is suitable for industrial production.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6564-72-3